Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03635450 · ClinicalTrials.gov registry record · Phase 1
Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE
A Phase 1 study, sponsored by Joanne Kurtzberg, MD.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT03635450 is a Phase 1 study that has completed, run by Joanne Kurtzberg, MD. The registered enrollment target is 6 participants.
The verdict
NCT03635450, a Phase 1 study, has completed, sponsored by Joanne Kurtzberg, MD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
To determine the safety of single and repeated intravenous doses of hCT-MSC in newborn infants with HIE.
Interventions
- BIOLOGICAL Infusion of hCT-MSC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-12-27 |
| Est. Completion | 2020-12-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03635450
The ClinicalTrials.gov registry entry for NCT03635450 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joanne Kurtzberg, MD, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Infusion of hCT-MSC is the first listed.
NCT03635450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03635450 about?
NCT03635450 is a clinical study titled "Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE". To determine the safety of single and repeated intravenous doses of hCT-MSC in newborn infants with HIE.
What is the current status of trial NCT03635450?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2018-12-27. Estimated completion is 2020-12-28.
What interventions are being tested in trial NCT03635450?
The interventions under investigation include: Infusion of hCT-MSC (BIOLOGICAL).
Who is sponsoring clinical trial NCT03635450?
This trial is sponsored by Joanne Kurtzberg, MD, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.